IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
